STAT

DECEMBER 7, 2023

Patent & Trademark Office granted two more patents, but did not do so until 2008. The move meant that the company, which is now part of Bristol Myers Squibb, won several more years of valuable patent protection than it would have received had it applied for the extra patents when submitting its data to the FDA.

Drug Pricing 321

Drug Pricing Compounding Pharmaceutical Companies Pharmaceutical Companies 321

STAT

SEPTEMBER 3, 2024

“That she took everything she knew about the pharmaceutical industry, having been part of it, and has really built a powerful advocacy for multiple myeloma patients, is remarkable,” said Tony Coles, who was CEO of Onyx Pharmaceuticals, a myeloma-focused biotech, from 2008 to 2014.

Drug Development 362

Drug Development 362

STAT

JUNE 20, 2024

” Founded in 2008 by five scientists from MIT, Ginkgo was once one of the hottest venture-backed startups in Boston. The company said it intended to “regain compliance with [the] NYSE’s continued listing standards and is considering all available options to do so.”

277

277

The Pharmacist

SEPTEMBER 4, 2024

Primary care staff need urgent support and training to care for people with food allergies, according to researchers who found that numbers have doubled since 2008. An analysis published in The Lancet Public Health said the largest rise had been seen in young children but the reasons behind the trend were not clear.

115

115

pharmaphorum

JULY 15, 2021

The price of a pack of 10mg tablets went from 70 pence in 2008 to £88 in 2016, according to the CMA, while a 20mg pack rose from £1.07 Before April 2008, the NHS was spending approximately £500,000 a year on hydrocortisone tablets, but that had swelled to £80 million by 2016. to £102.74.

119

119

Express Pharma

OCTOBER 18, 2023

As per the ICMR-INDIAB study conducted between October 17, 2008 and December 17, 2020, the overall weighted prevalence of diabetes was 11.4 per cent against the corresponding period last year (MAT August 2022).

Diabetes 105

Diabetes 105

The Guardian - Pharmaceutical Industry

AUGUST 7, 2022

According to one analysis of English newspapers , the number of articles stigmatising mental illness roughly halved between 2008 and 2016, while those challenging that stigma roughly doubled over the same period.

99

99

pharmaphorum

FEBRUARY 13, 2024

The alliance is with Roche Tissue Diagnostics (RTD), a unit of the Swiss pharma group that is concerned with the development of tissue-based tools to improve the diagnosis of cancer and grew out of Roche’s acquisition of Venta Medical Systems in 2008.

Drug Development 69

Drug Development 69

ALiEM - Pharm Pearls

SEPTEMBER 25, 2023

Epub 2008 Feb 15. References Bazan HA, Reiner E, Sumpio B. Management of bilateral phlegmasia cerulea dolens in a patient with subacute splenic laceration. Ann Vasc Dis. 2008;1(1):45-8. doi: 10.3400/avd.AVDcr07002. PMID: 23555338; PMCID: PMC3610218. Chaochankit W, Akaraborworn O. Phlegmasia Cerulea Dolens with Compartment Syndrome.

Medical Schools 152

Medical Schools Diabetes 152

Pharmaceutical Technology

OCTOBER 10, 2024

According to Lancet Public Health, the incidence of probable food allergy more than doubled in England between 2008 and 2018.

52

52

FADIC

AUGUST 11, 2023

Calculation of 2010 IF of a journal To calculate the 2010 Impact Factor of a journal, we would look at the citations received by the journal in 2010 and divide that number by the total number of articles published in the journal in 2008 and 2009.

91

91

Pharmaceutical Business Review

NOVEMBER 11, 2024

” Founded in 2008, Alteogen specialises in developing biologics, including ADCs, biobetters, and biosimilars. The company’s portfolio comprises clinical-stage long-acting therapeutic proteins and next-generation ADCs developed through its platform technologies, NexP-fusion and NexMab.

Biosimilars 98

Biosimilars 98

PharmaTech

NOVEMBER 1, 2024

The system is Hapman’s first major product launch since 2008, following a year of intensive R&D that builds upon the company’s eight decades of tubular drag conveyor expertise.

52

52

vizient

MARCH 7, 2024

offered feedback in response to the Administration’s proposed rule on updating requirements for the Mental Health Parity and Addiction Equity Act of 2008. Vizient, Inc.

52

52

pharmaphorum

JULY 21, 2022

” There will be no dramatic change in direction at Roche under the new CEO, according to Schwan, who was named CEO way back in 2008 and has been at the company throughout his entire career, joining the company in the early 1990s.

Biosimilars 119

Biosimilars 119

pharmaphorum

JUNE 6, 2022

It suggests that rep-accessible physicians – those who met ore than 70% of reps who approach them – has dwindled from 80% in 2008 to 44% in 2018, even before the pandemic brought face-to-face contact to a standstill.

118

118

pharmaphorum

JANUARY 18, 2022

In 2008, CVS Caremark, a prescription benefit management company, signed on to use Microsoft’s HealthVault. The 2008 collaboration was on a much smaller scale compared to their current partnership. However, it is not the first alliance between the two companies. COVID accelerated coalitions.

Prescription Filling 119

Prescription Filling 119

The Pharmacist

MARCH 1, 2024

Using health records of 236,506 people with asthma between 2008 and […] The post Poorly controlled asthma contributing to greenhouse gas emissions appeared first on The Pharmacist. Most of the carbon footprint comes from over-reliance on reliever inhalers, a study published in Thorax and carried out by Astra Zeneca found.

52

52

pharmaphorum

APRIL 13, 2021

Prior to joining Achieve Life Sciences in 2017, she served as OncoGenex’s executive vice president and chief medical officer since August 2008, and had been executive vice president and chief medical officer of OncoGenex Technologies Inc. from September 2005 to August 2008. The post Cytisinicline – the solution to stop smoking?

Drug Development 111

Drug Development 111

Safe Biologics

SEPTEMBER 27, 2024

Department of Health and Human Services from 2002-2008, including three years as Associate Deputy Secretary. A failure to do so will put patient health outcomes, and physician trust in these important medicines, in jeopardy. Michael Reilly served in the Office of the Secretary of the U.S. Read the oped at RealClearHealth

Biosimilars 100

Biosimilars 100

pharmaphorum

DECEMBER 23, 2020

It’s a major change of direction for Boston-based Agios, which has been concentrating on the oncology market since its inception in 2008, bringing the Bristol Myers Squibb-partnered Tibsovo (ivosidenib) for IDH1-mutant acute myeloid leukaemia to the US market.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

RX Note

MARCH 31, 2025

External Links American Academy of Dermatology Association - Cold Sores Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture, 2001 Natural remedies for Herpes simplex, 2006 Randomized clinical study comparing Compeed cold sore patch to acyclovir cream 5% in the treatment of herpes simplex labialis, (..)

Community Pharmacies 52

Community Pharmacies Chemotherapy 52

European Pharmaceutical Review

APRIL 3, 2023

In 2008, the ALK gene was found to hold a key role in the disease. Lorlatinib – could it change standard treatment for neouroblastoma? “This is in a population known to have inferior survival with standard-of-care, high-risk therapy,” Goldsmith explained.

Chemotherapy 97

Chemotherapy Hospitals 97

pharmaphorum

FEBRUARY 1, 2022

Since 2008, he has translated his work into the biomedical context for healthcare applications. His previous research resulted in patented systems for jet engine health monitoring, used with the engines of the Airbus A380, the Boeing 787 “Dreamliner” and the Eurofighter Typhoon.

Drug Development 104

Drug Development 104

European Pharmaceutical Review

DECEMBER 12, 2024

2008; 28(6A):35673572. Int J Gynecol Cancer. 2022; 32(6). Markert S, Lassmann S, Gabriel B, et al. Alpha-Folate Receptor Expression In Epithelial Ovarian Carcinoma And Non-Neoplastic Ovarian Tissue. Anticancer Res. The post Targeting ovarian cancer with a novel antibody therapeutic appeared first on European Pharmaceutical Review.

Chemotherapy 98

Chemotherapy 98

RX Note

JANUARY 25, 2024

External Links MyHEALTH - Food-Drug Interaction Dangerous Food-Drug Interactions, 2008 Food-Drug Interactions, 2011 On the other hand, we shall educate patients on potential drug-food interactions to minimize the risk.

52

52

RX Note

JULY 16, 2023

A comprehensive meta-analysis, 2008 Safety and Efficacy of Oral Polypodium leucotomos Extract in Healthy Adult Subjects, 2015

Mayo Clinic 52

Mayo Clinic 52

RX Note

AUGUST 11, 2024

External Links SafeMedication - How to Use Ear Drops Ansel's Pharmaceutical Dosage Forms and Drug Delivery System, 2018 Ear drops and ototoxicity, 2008 Aminoglycosides including gentamicin and neomycin) should be avoided in patients with perforations of the tympanic membrane.

Dosage 52

Dosage 52

Pharmaceutical Business Review

AUGUST 31, 2023

In March 2008, Kyowa Kirin signed a license agreement for Orkedia with Mitsubishi Tanabe Pharma for the rights for cooperative research, development, marketing and manufacturing of the drug in Japan and some parts of Asia.

Dosage 52

Dosage Compounding 52

Pharmacy Times

DECEMBER 8, 2022

Study finds textured breast implants do not increase the risk of anaplastic large-cell lymphoma, which has grown in incidence since 2008.

29

29

Pharma in Brief

NOVEMBER 1, 2020

The first chapter was a 2008 trial judgment upholding the validity of Servier’s patent for perindopril and finding that Apotex infringed the patent. Laboratoires Servier, Adir, Oril Industries, Servier Canada Inc v Apotex Inc , 2008 FC 825. Next was a 2015 trial judgment awarding an account of Apotex’s profits to Servier.

52

52

European Pharmaceutical Review

FEBRUARY 2, 2023

The last paracetamol plant in Europe, closed in France in 2008 as it was no longer economically sustainable, marking the exit of paracetamol manufacturing from Europe” The closure of API manufacturing plants in Europe started in earnest 15 years ago.

Generic Medicine 111

Generic Medicine Packaging Documentation Pharmaceutical Companies 111

pharmaphorum

APRIL 1, 2021

Bottomline is that KPI-based incentives will hardly ever create the behaviour that you want and in some of the worst examples have caused a disaster like the financial crisis in 2008. Pharma sales reps are rewarded in a very indirect way. Unlike salespeople in other industries, they don’t actually sell anything, they influence.

86

86

FDA Law Blog: Biosimilars

NOVEMBER 27, 2023

Walsh — Although the Consumer Product Safety Act (CPSA) has been around for over 50 years to “protect the public against unreasonable risks of injury associated with consumer products,” it was not until 2008 that the statute was amended to authorize the Consumer Product Safety Commission (“CPSC”) to impose criminal liability against individual directors, (..)

104

104

pharmaphorum

OCTOBER 19, 2020

The triple aim considers how we balance the needs of the individual with pressures on our health systems and, in a phrase coined by Berwick, Nola and Whittington in 2008, it is defined as: Improving an individual’s experience of care. Improving the health of populations. Reducing the per capita costs of care.

Communication 128

Communication Diabetes Hospitals 128

Eye on FDA

AUGUST 2, 2022

These 4 letters related to 5 different communications vehicles, 4 of which involved digital forms of communications – 2 were videos, 1 was a web page and 1 was an Instagram posting, one of the rare letters involving a social media platform.

Communication 88

Communication Pharmaceutical Companies Pharmaceutical Companies Documentation 88

pharmaphorum

JANUARY 4, 2023

The drug was originally developed by CV Therapeutics – bought by Gilead in 2009 – and first launched in the US in 2008. According to IQVIA figures, US sales of Lexiscan were approximately $650 million for the 12 months that ended 31 March 2022, making it one of Astellas’ top products. It is sold as Rapiscan in Europe by GE Healthcare.

Generic Medicine 59

Generic Medicine 59